Patrys Limited Issues New Shares to Strengthen Financial Position
Patrys Limited has issued 308,362,535 fully paid ordinary shares at $0.001 each to sophisticated and professional investors, as part of a placement to strengthen its financial position in the biotechnology sector. This action complies with the Corporations Act and reflects the company's ongoing efforts to secure funding. Patrys Limited, based in Melbourne, focuses on developing its deoxymab platform of cell-penetrating antibodies for various therapeutic indications. The current market cap is A$3.09M.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Patrys Limited ( (AU:PAB) ) has provided an update.
Patrys Limited has issued 308,362,535 fully paid ordinary shares at $0.001 per share to sophisticated and professional investors, as part of a placement announced earlier. This move is in compliance with the Corporations Act and signifies the company’s ongoing efforts to secure funding and strengthen its financial position in the biotechnology sector.
More about Patrys Limited
Based in Melbourne, Australia, Patrys Limited (ASX:PAB) focuses on developing its deoxymab platform of cell-penetrating antibodies for various therapeutic indications.
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$3.09M
Find detailed analytics on PAB stock on TipRanks’ Stock Analysis page.
Trending Articles:
- Cantor Bangs the Drum on Tesla Stock
- D-Wave Quantum Stock Scores a New Street-Hight Price Target
- Paramount (NASDAQ:PARA) “Paralyzed by Legal Fears” as Deadlines Approach
Disclaimer & Disclosure
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue